Pharmalot Archives

Pharmalot By Ed Silverman

Pharmalittle: Pfizer resists requests for study supplies of its Covid pill; WTO talks on Covid vaccine patent waivers are bogged down

Pharmalot By Ed Silverman

Drugmakers win court battle over an HHS rule that would have penalized them for offering copay coupons

Pharmalot By Ed Silverman

‘Pharma bro’ Martin Shkreli released from prison

Pharmalot By Ed Silverman

Pharmalittle: Moderna chair defends executive hiring process; analysis finds monopoly tactics preserve inhaler revenues

Pharmalot By Ed Silverman

Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver

Pharmalot By Ed Silverman

Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists it can overcome latest setback

Pharmalot By Ed Silverman

Pharmalittle: Seagen chief executive is arrested for domestic assault; abortion pill producer has ample supplies

Pharmalot By Ed Silverman

Lawmakers wade into a contentious battle over orphan drug monopolies

Pharmalot By Ed Silverman

Pharmalittle: Moderna’s new CFO leaves due to probe by former employer; Roche suffers another setback with a cancer drug

Pharmalot By Ed Silverman

Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic

Pharmalot By Ed Silverman

Pharmalittle: Pfizer to pay $11.6 billion for Biohaven; pharmacy chains face a novel trial to determine opioid liability

Pharmalot By Damian Garde

Pharmalittle: Seagen CEO under investigation after alleged domestic violence; Bausch & Lomb settles for a lesser IPO

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FDA restricts access to J&J Covid-19 vaccine; Novartis halts production of two cancer drugs over quality issues

Pharmalot By Ed Silverman

Novartis suspends production of two cancer therapies over potential quality issues

Pharmalot By Ed Silverman

Pharmalittle: Abortion pill demand may rise if Roe v Wade is overturned; U.S. lawmakers move toward revamping accelerated approval

Pharmalot By Ed Silverman

J&J sues a behind-the-scenes company for exploiting its patient assistance program

Pharmalot By Ed Silverman

Race is often overlooked in key clinical trial data used to win new drug approvals in Europe

Pharmalot By Ed Silverman

FDA warns Miami University contract testing lab over falsified data, poor quality control

Pharmalot By Ed Silverman

Pharmalittle: Biogen is perilously poised for the future; WTO advances controversial Covid-vaccine patent waiver

Pharmalot By Ed Silverman

A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO

Pharmalot By Ed Silverman

Pharmalittle: Biogen CEO exits amid Aduhelm failures; FDA eschews its own outside expert panels

Pharmalot By Ed Silverman

Is the FDA taking advice from its expert panels? A new analysis points to inconsistencies in the process

Pharmalot By Ed Silverman

U.N. committee urges wealthy nations to honor human rights and widen access to Covid vaccines

Pharmalot By Ed Silverman

Most Read

Drugmakers use monopoly tactics to thwart lower-cost generic competition for inhalers, analysis finds

High blood pressure pills are costly — but also hard to find — in some lower-income countries

Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program

Greece plans to go to court to seek compensation from Novartis over a bribery scandal

Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge

Up and down the ladder: The latest comings and goings

National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program

Arkansas becomes the latest state to sue drugmakers and PBMs over insulin pricing

All Coverage

Pharmalittle: Pfizer resists requests for study supplies of its Covid pill; WTO talks on Covid vaccine patent waivers are bogged down

Drugmakers win court battle over an HHS rule that would have penalized them for offering copay coupons

‘Pharma bro’ Martin Shkreli released from prison

Pharmalittle: Moderna chair defends executive hiring process; analysis finds monopoly tactics preserve inhaler revenues

Pharmalittle: FDA declines to approve old antidepressant for Covid; U.S.-China trade fight may derail WTO Covid patent waiver

Pharmalittle: Aspen may close South Africa Covid vaccine plant due to lack of orders; Roche insists it can overcome latest setback

Pharmalittle: Seagen chief executive is arrested for domestic assault; abortion pill producer has ample supplies

Lawmakers wade into a contentious battle over orphan drug monopolies

Pharmalittle: Moderna’s new CFO leaves due to probe by former employer; Roche suffers another setback with a cancer drug

Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic

Pharmalittle: Pfizer to pay $11.6 billion for Biohaven; pharmacy chains face a novel trial to determine opioid liability

Pharmalittle: Seagen CEO under investigation after alleged domestic violence; Bausch & Lomb settles for a lesser IPO

Up and down the ladder: The latest comings and goings

Pharmalittle: FDA restricts access to J&J Covid-19 vaccine; Novartis halts production of two cancer drugs over quality issues

Novartis suspends production of two cancer therapies over potential quality issues

Pharmalittle: Abortion pill demand may rise if Roe v Wade is overturned; U.S. lawmakers move toward revamping accelerated approval

J&J sues a behind-the-scenes company for exploiting its patient assistance program

Race is often overlooked in key clinical trial data used to win new drug approvals in Europe

FDA warns Miami University contract testing lab over falsified data, poor quality control

Pharmalittle: Biogen is perilously poised for the future; WTO advances controversial Covid-vaccine patent waiver

A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO

Pharmalittle: Biogen CEO exits amid Aduhelm failures; FDA eschews its own outside expert panels

Is the FDA taking advice from its expert panels? A new analysis points to inconsistencies in the process

U.N. committee urges wealthy nations to honor human rights and widen access to Covid vaccines

Pharmalittle: FDA declines to approve two more drugs tested in China; Pfizer Covid pill fails to prevent infection in household members